Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Scopolamine-physostigmine combination does not substitute for nicotine

M D Schechter1

  • 1Department of Pharmacology, Northeastern Ohio Universities College of Medicine, Rootstown, USA.

Progress in Neuro-Psychopharmacology & Biological Psychiatry
|May 1, 1995
PubMed
Summary

Nicotine discrimination in rats may involve non-cholinergic mechanisms. Combining a cholinesterase inhibitor with an anti-muscarinic drug did not produce nicotine-like effects, suggesting complex pathways beyond acetylcholine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Continued trends in the conditioned place preference literature from 1992 to 1996, inclusive, with a cross-indexed bibliography.

Neuroscience and biobehavioral reviews·1998
Same author

'Candyflipping': synergistic discriminative effect of LSD and MDMA.

European journal of pharmacology·1998
Same author

Olanzapine attenuates the reinforcing effects of cocaine.

European journal of pharmacology·1998
Same author

MDMA-like stimulus effects of hallucinogens in male Fawn-Hooded rats.

Pharmacology, biochemistry, and behavior·1998
Same author

Rohypnol ("roofies") control of drug discrimination: effect of coadministered ethanol or flumenazil.

Pharmacology, biochemistry, and behavior·1998
Same author

LSD produces conditioned place preference in male but not female fawn hooded rats.

Pharmacology, biochemistry, and behavior·1998

Area of Science:

  • Neuroscience
  • Pharmacology
  • Behavioral Science

Background:

  • Nicotine's discriminative stimulus effects are well-established.
  • Understanding the neurochemical basis of nicotine discrimination is crucial for developing targeted therapeutics.

Purpose of the Study:

  • To investigate the role of cholinergic mechanisms in nicotine discrimination.
  • To explore whether combining a cholinesterase inhibitor (physostigmine) with an anti-muscarinic agent (scopolamine) could mimic or modulate nicotine's effects.

Main Methods:

  • Male Sprague-Dawley rats were trained on a food-motivated operant task to discriminate nicotine (0.4 mg/kg) from saline.
  • Physostigmine and scopolamine were co-administered in various doses to assess their effects on nicotine discrimination.
  • Dose-response relationships and discriminative effects were analyzed.

Related Experiment Videos

Main Results:

  • Nicotine discrimination was dose-dependent, with an ED50 of 0.11 mg/kg.
  • Co-administration of physostigmine and scopolamine produced intermediate responding, neither fully nicotine-like nor saline-like.
  • The drug combination did not substitute for or enhance nicotine's discriminative effects.

Conclusions:

  • The combination of a cholinesterase inhibitor and an anti-muscarinic agent does not replicate nicotine's discriminative effects.
  • These findings suggest that nicotine discrimination may involve non-cholinergic pathways.
  • Nicotinic receptor function in discrimination tasks might be more complex than initially hypothesized through solely cholinergic modulation.